Lead Discovery Center and Bayer enter into license agreement covering a novel pharmaceutical lead structure
Out-licensing of the first pharmaceutical lead structure generated at the Lead Discovery
Center for further development into a cancer therapy
21-Apr-2011 -
The Lead Discovery Center GmbH (LDC), based in Dortmund, Germany, a spin-off from Max-Planck-Innovation GmbH (MI) in Munich, with expertise in small molecule pharmaceutical drug discovery, has successfully licensed its first lead structure to a pharma partner. The agreement grants Bayer Schering ...
Bayer
Bayer HealthCare
Bayer Schering
+2